Principal Data Scientist @UTMDAnderson. Focusing on AI for pathology and omics, multimodal integration, and their translation to cancer biology and clinic.
I really think this agentic framework points toward how personalized healthcare can be delivered in the future. Lung cancer pathology serves as an strong example here, while this framework can extend to accommodate across kinds of data modalities, diseases, and questions.
First-in-class targeted therapy, a RAS inhibitor, is approved for advanced pancreatic cancer by FDA. In a randomized multicenter clinical trial involving 500 adults, with previously treated metastatic pancreatic adenocarcinoma, the therapy improved median overall survival to 13.2
